The Andalucia – Roche Alliance celebrates one year of life, during which, despite the impact of COVID-19, the scientific project is developing within a certain normality, as shown in the commemorative video with the milestones achieved.
The Andalucía – Roche Alliance held a WORKSHOP in Córdoba, bringing together members of the Alliance from the 3 research nodes: IMIBIC, IBIMA and IBIS, from Roche and FPS to share the most relevant scientific results of their research lines.
Javier Salvador’s team, from the Virgen del Rocio Hospital , will present these results at an international congress on this pathology to be held in December in the USA. Researchers from the Andalucia-Roche Alliance, in which the Regional Ministry of Health and Families and the pharmaceutical company Roche participate, have identified a possible biomarker in […]
The Regional Ministry of Health and Families and the pharmaceutical company Roche continue to promote a project that seeks to find personalised diagnostic and treatment methods for breast, lung, colorectal and pancreatic cancer.The advances can be found on the Alliance’s new website: https://www.juntadeandalucia.es/salud/alianza-andalucia-roche/ A total of 683 samples from patients with breast, lung, colorectal and […]
The “New therapies in cancer” research group at IMIBIC, led by Enrique Aranda, is working on the implementation of liquid biopsy as a diagnostic method and on personalised preclinical models, by culturing cells from the patient’s tumour in the laboratory. The Andalusia-Roche Alliance, an agreement between the Progress and Health Foundation of the Regional Ministry […]
Breast, lung, colorectal and pancreatic cancers are the focus of research in this precision medical oncology strategy launched by the Regional Ministry of Health and Families and the pharmaceutical company Roche, in which public hospitals in Cordoba, Malaga and Seville are participating. Almost 300 samples from patients with breast, lung, colorectal and pancreatic cancer are […]
IMIBIC’s ‘New therapies in cancer’ group has initiated this line of research to obtain molecular information on this type of tumour, by means of liquid biopsy, which may be relevant for diagnosis, treatment and monitoring of patients’ response to therapies. Discovering new biomarkers to ensure early detection of pancreatic cancer, making a more accurate prognosis […]
The promotion of translational research, led from the clinic, to achieve innovative solutions for patients with breast, lung, colorectal or pancreatic cancer is the objective of a public-private alliance between the Regional Ministry of Health and Families and Roche Farma. The scientific objectives of this strategic alliance in precision medical oncology include the development of […]
This public-private initiative, which has a joint budget of 2.4 million euros until 2022, will involve research groups from the Andalusian Public Health System focused on translational research in lung, breast and colorectal cancer. The Alliance aims to promote precision medical oncology in Andalusia by improving early diagnosis strategies, knowledge of the cancer microbiome and […]
